Evaluation of Zanthoxylum armatum DC for in-vitro and in-vivo pharmacological screening

被引:0
|
作者
Barkatullah [1 ]
Ibrar, Muhammad [1 ]
Muhammad, Naveed [2 ]
机构
[1] Univ Peshawar, Dept Bot, Peshawar, Pakistan
[2] Univ Peshawar, Dept Pharm, Peshawar, Pakistan
来源
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY | 2011年 / 5卷 / 14期
关键词
Zanthoxylum armatum; antipyretic; phytotoxic; cytotoxic; CONSTITUENTS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The crude ethanolic extract of leaves(ZLE) and fruits (ZFE) of Zanthoxylum armatum were scrutinized for acute toxicity and antipyretic activities while crude ethanolic and n-hexane extract of the leaves (ZLE, ZLH) and fruits (ZLE, ZLH) of this plant were screened out for their phytotoxic and cytotoxic potential. The extract were found to be safe at a dose of 500, 1000 and 2000 mg/kg body weight. The antipyretic activity of leaves and fruits were tested on mice using Brewer's yeast induced pyrexia model, both the extract, that is, ZLE and ZFE were found to active in lowering pyrexia in the tested animals. The antipyretic effect of fruits was more significant than leaves. ZFE showed a percent inhibition of 83.84, 80.70 and 44.18 at the dose of 300, 200 and 100 mg/kg, respectively at the 3rd hour while ZLE showed a percent inhibition of 85.42, 77.19 and 46.18 respectively at the dose of 300, 200 and 100 mg/kg, respectively. The antipyretic action was observed to be maximum at the 3rd hour of the dose, which remain significant up to 5th hour. The ZLE, ZLH, ZFE and ZFH also showed significant potency as phytotoxic and cytotoxic agent. Phytotoxicity and cytotoxicity were found to be dose dependant and showed maximum efficiency at 1000 mu g/ml. It is concluded that Z. armatum a potential antipyretic, phytotoxic and cytotoxic medicinal plant. Further investigations are required to identify and isolate its active principals responsible for its pharmacological activities.
引用
收藏
页码:1718 / 1723
页数:6
相关论文
共 50 条
  • [31] Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles
    Mohamed S. Mohamed
    Wael A. Abdelhafez
    Gamal Zayed
    Ahmed M. Samy
    AAPS PharmSciTech, 21
  • [32] IN-VITRO AND IN-VIVO EVALUATION OF A TEMPORARY BIODEGRADABLE WOUND DRESSING
    JURGENS, C
    BEUCHEL, M
    BISGWA, F
    DEKKER, A
    HAFEMANN, B
    KORTMANN, HR
    NIENDORF, A
    PARTECKE, BD
    PORTE, T
    SCHULTZ, JH
    UNFALLCHIRURG, 1995, 98 (04): : 241 - 247
  • [33] Screening for Amyloid Aggregation: In-Silico, In-Vitro and In-Vivo Detection
    Villar-Pique, Anna
    Espargaro, Alba
    Ventura, Salvador
    Sabate, Raimon
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (05) : 477 - 489
  • [35] In-vitro and in-vivo evaluation of the antibacterial potential of Typha elephantina
    Ahmad, B.
    Yousafzai, A. M.
    Zeb, A.
    Khan, A. A.
    Attaullah, M.
    Ahmad, S.
    TROPICAL BIOMEDICINE, 2021, 38 (01) : 1 - 7
  • [36] IN-VITRO AND IN-VIVO MODELS FOR ANTIOXIDANT ACTIVITY EVALUATION: A REVIEW
    Joseph, N. M.
    Monika, Sabharwal
    Alok, Shashi
    Alok, Mahor
    Shruti, Rawal
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (01):
  • [37] IN-VITRO AND IN-VIVO EVALUATION OF ANTI-CALCULUS AGENTS
    BRINER, WW
    FRANCIS, MD
    CALCIFIED TISSUE RESEARCH, 1973, 11 (01): : 10 - 22
  • [38] RETRIEVABLE IVC FILTER - PRELIMINARY IN-VITRO AND IN-VIVO EVALUATION
    IRIE, T
    YAMAUCHI, T
    MAKITA, K
    KUSANO, S
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (03) : 449 - 454
  • [39] In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration
    Liu, Chunmei
    Shi, Jing
    Dai, Qingyun
    Yin, Xiaoxing
    Zhang, Xiaoyan
    Zheng, Aiping
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (02) : 272 - 278
  • [40] EVALUATION OF THE MUTAGENICITY OF ALPHA-DIHYDROERGOCRYPTINE IN-VITRO AND IN-VIVO
    ADAMS, K
    ALLEN, JA
    BROOKER, PC
    JONES, E
    PROUDLOCK, RJ
    MAILLAND, F
    COPPI, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-2 (12): : 1253 - 1257